Loss of function of p16 gene and prognosis of pulmonary adenocarcinoma

Cancer

Volumn 103, Issue 3, 2005, Pages 608-615

  Tanaka, Ryota ^a,b   Wang, Daye ^b   Morishita, Yukio ^b   Inadome, Yukinori ^b   Minami, Yuko ^b   Iijima, Tatsuo ^b   Fukai, Shimao ^c   Goya, Tomoyuki ^a   Noguchi, Masayuki ^b  

^a KYORIN UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c The Center of Chest Diseases and Severe Motor Intellectual Disabilities   (Japan)

Author keywords

Carcinogenesis; CpG island methylation; Immunohistochemistry; Loss of heterozygosity; Nonsmall cell lung carcinoma; p16; Prognostic factor; Pulmonary adenocarcinoma; Stepwise progression; Tumor suppressor gene

Indexed keywords

GENE PRODUCT; PROTEIN P16;

ADULT; AGED; ARTICLE; CPG ISLAND; DISEASE CLASSIFICATION; FEMALE; GENE FUNCTION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METHYLATION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 9; CPG ISLANDS; DNA METHYLATION; FEMALE; GENES, P16; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROMOTER REGIONS (GENETICS); RISK FACTORS;

EID: 12744280715     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20827     Document Type: Article

References (17)

1. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histological typing of lung and pleural tumours. Berlin: Springer Verlag, 1999.
2. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung-histologic characteristics and prognosis. Cancer. 1995;75:2844-2852.
3. Gazzeri S, Gouyer V, Vourc'h C, Brambilla C, Brambilla E. Mechanisms of p16(INK4A) inactivation in non small-cell lung cancers. Oncogene. 1998;16:497-504.
4. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 1994;368:753-756.
5. Kamb A, Gruis NA, Weaverfeldhaus J, et al. A cell-cycle regulator potentially involved in genesis of many tumor types. Science. 1994;264:436-440.
6. Merlo A, Herman JG, Mao L, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumor-suppressor p16/CDKN2/MTS1 in human cancers. Nature Med. 1995;1:686-692.
7. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. 1997;111:1710-1717.
8. Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun. 1985;130:118-126.
9. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996; 93:9821-9826.
10. Palmisano WA, Divine KK, Saccomanno G, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 2000;60:5954-5958.
11. Suter CM, Norrie M, Ku SL, Cheong KF, Tomlinson I, Ward RL. CpG island methylation is a common finding in colorectal cancer cell lines. Br J Cancer. 2003;88:413-419.
12. Zhu W, Zou H, Beck A, et al. Loss of heterozygosity in primary lung cancer using laser capture microdissection and WAVE DNA fragment analysis techniques. Med Sci Monit. 2002;8:BR95-BR99
13. Kurasono Y, Ito T, Kameda Y, Nakamura N, Kitamura H. Expression of cyclin D1, retinoblastoma gene protein, and p16 MTS1 protein in atypical adenomatous hyperplasia and adenocarcinoma of the lung-an immunohistochemical analysis. Virchows Arch. 1998;432:207-215.
14. Semczuk A, Boltze C, Marzec B, Szczygielska A, Roessner A, Schneider-Stock R. p16(INK4A) alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas. J Cancer Res Clin Oncol. 2003;129:589-596.
15. Belinsky SA, Nikula KJ, Palmisano WA, et al. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA. 1998;95:11891-11896.
16. Wistuba II, Behrens C, Milchgrub S, et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene. 1999;18: 643-650.
17. Toyooka S, Maruyama R, Toyooka KO, et al. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int J Cancer. 2003;103:153-160.